Should I get gene expression profiling to assess recurrence risk
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Gene Expression Profiling for Melanoma Recurrence Risk
That's an important question to discuss with your oncology team. Let me explain what gene expression profiling is and how it relates to melanoma care.
What Gene Expression Profiling Does
Gene expression profiling is a test that measures which genes are "turned on" or "turned off" in your melanoma cells. This activity pattern can help predict how aggressive your cancer might be and whether it's more likely to come back.
Current Role in Melanoma Care
According to the NCCN Guidelines for Patients: Melanoma (2025), the standard testing approach for melanoma includes:
- BRAF mutation testing (if not already done) - This is the primary genetic test recommended for melanoma
- Biomarker assessment to guide treatment decisions
- Clinical staging based on tumor characteristics like Breslow thickness (how deep the tumor grew) and other pathologic features
The NCCN guidelines emphasize that accurate testing is needed to correctly identify the type of melanoma and see if it has spread. However, the current standard recommendations focus on BRAF and other specific mutations rather than broader gene expression profiling as a routine recurrence risk assessment tool.
Questions to Ask Your Oncologist
Since gene expression profiling isn't universally recommended in standard NCCN guidelines, here are specific questions for your care team:
- "Based on my specific melanoma characteristics (stage, thickness, ulceration), what is my recurrence risk?"
- "Do you recommend gene expression profiling for my situation, and if so, which test?"
- "How would the results of gene expression profiling change my treatment plan?"
- "Are there clinical trials using gene expression profiling that might be appropriate for me?"
- "What other biomarkers or tests do you recommend to assess my recurrence risk?"
Important Context
Your oncologist will consider your complete clinical picture—including your melanoma stage, tumor characteristics, and whether you've had any recurrence—to determine which tests are most helpful for your specific situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Melanoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with prognosis for Melanoma patients
Have your records handy? Upload them for a deeper, personalized analysis →